University Hospital Münster
Münster, Germany
NCT Number: NCT04277728
Intravenous thrombolysis is recommended within 4.5 hours of stroke onset. The aim of the study is to evaluate whether a hypodensity on native CT within the virtually entire area of hypoperfusion on perfusion CT, i.e. hypoperfusion-hypodensity mismatch, identifies patients within the time window of thrombolysis in a multicenter cohort. The investigators hypothesize hypoperfusion-hypodensity mismatch will identify patients ≤ 4,5 hours of symptom onset with >70% specificity and >85% positive predictive value.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Münster, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
hypoperfusion-hypodensity mismatch on computed tomography
Time frame: on admission
Time frame: on admission
University Hospital Muenster
Other
Mismatch Between Hypoperfusion and Hypodensity on CT for the Identification of Patients With Stroke Onset Within 4.5 Hours
Acronym: MissPerfeCT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05953480
Acute Ischemic Stroke, Brain Diseases
Tucson, Arizona, United States
View Trial DetailsNCT05965687
Acute Ischemic Stroke, Brain Diseases
Beijing, China
View Trial DetailsNCT06101667
Acute Ischemic Stroke, Basilar Artery Occlusion
Beijing, Beijing Municipality, China
View Trial DetailsNCT06638151
Acute Ischemic Stroke, Brain Diseases
Edmonton, Alberta, Canada
View Trial Details